See also <!DOCTYPE html><html lang="en"><head> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title>3 Stock Spinoffs Poised for Market Domination</title></head><body> <div> <h2>The Forgotten Gold Mine: Hidden Value in Spinoff Stocks</h2> <p>Spinoff stocks have long been cast aside by investors, deemed as unwanted remnants of bigger entities. However, diving deep into the world of spinoffs reveals a treasure trove waiting to be discovered. As investing guru Joel Greenblatt highlights in his timeless masterpiece "You Can Be a Stock Market Genius," these castaways often harbor unrealized potential when set free.</p> <h2>Solventum (SOLV): A Diamond in the Rough</h2> <p><strong>Solventum</strong> (NYSE:<span class="stock-ticker"><strong><u>SOLV</u></strong></span>) emerges as a promising player in the healthcare landscape after being spun off from industrial giant <strong>3M</strong> (NYSE:<span class="stock-ticker"><strong><u>MMM</u></strong></span>). With a stronghold in sterilization devices, dressings, tapes, this $8.2 billion revenue giant is ready to conquer. Despite a sluggish start post-separation, boasting revenues of $2 billion and $2.08 per share earnings, the stock remains undervalued. Priced at a discount due to an $8.3 billion debt burden from its previous parent, Solventum is on the path to redemption, making it a beacon in the sea of mediocrity.</p> <h2>Kenvue (KVUE): Unleashing Consumer Power</h2> <p><strong>Kenvue</strong> (NYSE:<span class="stock-ticker"><strong><u>KVUE</u></strong></span>) struts into the consumer health sector post its emancipation from <strong>Johnson & Johnson</strong> (NYSE:<span class="stock-ticker"><strong><u>JNJ</u></strong></span>). The custodian of iconic brands like Tylenol, Listerine, or Band-Aid, this $15 billion powerhouse flexes its muscles. With a formidable dividend legacy inherited from its erstwhile parent, Kenvue stands tall despite a 24% drop since its inception. Like a phoenix rising from the ashes, Kenvue is poised to soar high on the wings of trust and quality.</p> <h2>W.K. Kellogg (KLG): A Breakfast of Champions</h2> <p>If you had cereal for breakfast, chances are it bore the imprint of <strong>W.K. Kellogg</strong> (KLG). Stepping out of the shadows of its parent, this stalwart in the breakfast food industry is no stranger to your morning routine. With a legacy as rich as your favorite cornflakes, W.K. Kellogg is a stock to watch, destined to nurture portfolios much like it nurtures bodies.</p> </div></body></html><!DOCTYPE html><html><head> <title>The Rise of W.K. Kellogg in a Shrinking Cereal Market</title></head><body> The Rise of W.K. Kellogg in a Shrinking Cereal Market